Massivemarkets

SEC Form 4

Rocket Pharmaceuticals, Inc. (RCKT) insider trading

In the 12 months to Nov 15, 2026, 6 RCKT insiders reported open-market sales of $1.0M across 27 filings; one director bought $34.4K.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$1.0M
27 filings · 6 insiders
Open-market purchases
$34.4K
1 filing · Elisabeth Bjork, Director

Who traded RCKT, and when

  • Purchase
  • Sale

RCKT daily close from Nov 17, 2025 to Nov 13, 2026, between $2.18 and $5.30, last $2.30. 27 sale and 1 purchase filings by 7 insiders, marked at their filing dates. Martin Wilson, General Counsel: sold $462.4K across 9 filings, first filed Nov 20, 2025, last Nov 9, 2026. Gaurav Shah, CEO: sold $285.7K across 8 filings, first filed Nov 20, 2025, last Aug 20, 2026. Christopher James Stevens, Chief Operating Officer: sold $128.3K across 1 filing, first filed Aug 13, 2026, last Aug 13, 2026. Sarbani Chaudhuri, Officer (see filing): sold $95.5K across 3 filings, first filed May 11, 2026, last Nov 12, 2026. Elisabeth Bjork, Director: bought $34.4K across 1 filing, first filed Jan 6, 2026, last Jan 6, 2026. John Militello, Officer (see filing): sold $23.7K across 5 filings, first filed Nov 20, 2025, last May 21, 2026. Jonathan David Schwartz, Officer (see filing): sold $7.6K across 1 filing, first filed Nov 20, 2025, last Nov 20, 2025.

Largest mark · tap a row for others

Martin Wilson · General Counsel

Sale $256,464

75,364 shares at $3.40 avg

Filed Sep 15, 2026 · traded Sep 11

Close on filing date $3.41

RCKT daily closelast $2.30

Martin Wilson · General Counsel

$462.4K sold

Gaurav Shah · CEO

$285.7K sold

Christopher James Stevens · Chief Operating Officer

$128.3K sold

Sarbani Chaudhuri · Officer (see filing)

$95.5K sold

Elisabeth Bjork · Director

$34.4K bought

John Militello · Officer (see filing)

$23.7K sold

Jonathan David Schwartz · Officer (see filing)

$7.6K sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

28 filings in the last 12 months
Other insider activity (not market trades) · 15 records
  • Option exercises1 record
  • Grants and awards13 records
  • Other1 record

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

Frequently asked questions

Has Rocket Pharmaceuticals, Inc.'s CEO sold stock?

Yes. Gaurav Shah (CEO) sold 90,496 shares ($285.7K) between Nov 2025 and Aug 2026.

How current is RCKT’s insider data?

These are RCKT Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track RCKT insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for RCKT every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.